Skip to content

GCL

Analysis: Longi mono wafer expansion plans could yield H2 oversupply

Independent solar analyst, Corrine Lin believes that Longi’s plans to triple monocrystalline wafer production capacity to 45 GW by 2020 could trigger an oversupply problem in the second half of this year.

2

It’s settled: GCL-Poly resolves legal dispute with Solaria

Intellectual Property claim filed by U.S. firm Solaria against GCL-Solar in September 2016 has been resolved on mutually agreeable terms, GCL-Poly said. Exact details of the settlement were not disclosed.

4

Singulus establishes joint venture with Chinese heterojunction companies

Singulus has signed an agreement with two Chinese PV providers to form a joint venture in the field of the heterojunction technology. The joint venture will be based in China.

GCL New expects H1 profit on 1 GW of capacity

GCL New Energy will likely post a profit of CNY 450 million ($67.4 million) in the first half of 2017, from a profit  of just CNY 147 million a year earlier, as it connected 1.04 GW of new solar capacity to the grid.

GCL New, CEE sign $62.3 million deal for 100 MW

A unit of Beijing-based China Energy Engineering (CEE) has agreed to build a 100 MW solar project for GCL New Energy in eastern China.

GCL-SI signs Mexican distribution deal with DMSolar

GCL System Integration (GCL-SI) did not disclose the financial terms of the master distribution agreement, under which Guadalajara-based DMSolar will offer the Chinese PV maker’s components, as well as its GCL-P6/60 and GCL-P6/72 panels.

The pv magazine weekly news digest

2017 begins with yet more positive price reduction momentum, while Spain reveals details of its renewables auction and Comtec Solar and Longi agree to asset purchase.

This website uses cookies to anonymously count visitor numbers. View our privacy policy.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close